Kei Ito, Yujiro Nakajima, Shota Minakami, Yumiko Machitori, Yukio Hosomi, Kana Hashimoto, Makoto Saito, Keiko Nemoto Murofushi. Prophylactic cranial irradiation for limited-stage small-cell lung cancer in the modern magnetic resonance imaging era may be omitted: a propensity score-matched analysis. Journal of Radiation Research. 2024
Ryosuke Kita, Kei Ito, Ryunosuke Machida, Yuta Sekino, Naoki Nakamura, Yujiro Nakajima, Tetsuo Saito, Nobuki Imano, Haruhiko Fukuda, Yoshinori Ito, et al. Randomized phase III study comparing re-irradiation stereotactic body radiotherapy and conventional radiotherapy for painful spinal metastases: Japan Clinical Oncology Group study JCOG2211 (RESCORE study). Japanese Journal of Clinical Oncology. 2024
Fumiya Tsurumaki, Yujiro Nakajima, Kei Ito, Satoshi Kito, Riki Kikumura, Keiko Nemoto Murofushi, Atsunori Yorozu, Yukio Fujita. Optimal combination of collimator angles for dual-arc volumetric modulated arc therapy planning in stereotactic body radiotherapy for spinal metastases. Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 2024
Hideyuki Harada, Naoto Shikama, Akifumi Notsu, Hiroki Shirato, Kazunari Yamada, Haruka Uezono, Yutaro Koide, Hikaru Kubota, Takuya Yamazaki, Kei Ito, et al. Multi-institutional prospective observational study of radiotherapy for metastatic bone tumor. Journal of radiation research. 2024
Kei Ito, Yujiro Nakajima, Kentaro Taguchi, Hiroaki Ogawa, Makoto Saito, Keiko Nemoto Murofushi. Phase II Clinical Trial of Second Course of Stereotactic Body Radiotherapy for Spinal Metastases. Cancers. 2024. 16. 12. 2286-2286